Mechanism And Translational Potential of Grape Seed Extract in Dysmenorrhea and Endometriosis

Despite their repeated abandonment, grape seeds and wine industry by-products contain a variety of beneficial bioactive components. Grape Seed Extract (GSE), derived from the seeds of Vitis vinifera, is one supplement that transforms what was formerly considered vineyard waste into a health benefit. Strong antioxidants called polyphenols account for 20–55% of the weight of a grape seed. Perhaps the most well-known of these are oligomeric proanthocyanidins (OPCs), which are widely known for their ability to reduce inflammation and cellular damage. Each grape seed contains between 20 and 55 percent polyphenols, a powerful antioxidant. One of the things that makes GSE more attractive is that it can affect multiple biosystems instead of just one.^[71] Blocking the calcium channels that trigger muscle spasms can alleviate endometriosis and menstrual discomfort by reducing uterine contractions. reducing TNF-alfa and other inflammatory cytokines associated with tissue irritation and pain. According to preliminary study, it might also alter estrogen activity, which is connected to issues related to reproductive health. Benefits for the heart alleviating the condition known as chronic venous insufficiency, which reduces blood flow from the legs. overall circulatory health by enhancing blood pressure control and maintaining arterial flexibility. By blocking the COX-2 enzyme, it lessens pain and inflammatory signals similarly to nonsteroidal anti-inflammatory drugs. It activates the Nrf2 pathway, which tells cells to make their own antioxidants to fight oxidative damage. By controlling calcium entrance and inflow, it keeps muscles from being overexcited. It also raises nitric oxide and encourages vasodilation, both of which improve blood flow. A daily dose of 150–475 mg, which is standardized to contain 70–85% OPCs, has been found to be an effective strategy to give the active chemicals rather than the inert seed hull.

Sources Of Literature

A thorough literature search was carried out for this review using electronic databases such as PubMed, Scopus, Web of Science, Google Scholar, and Science Direct. Included were reviews, preclinical research, clinical trials, and peer-reviewed original research articles published until 2025.

Grape Seed Extract ( GSE )

Phramacognostic studies of Grape Seeds

Because of their high concentration of active chemicals and wide range of therapeutic potential, grape seeds are one of the most studied plant materials in pharmacognosy.

 

 

 

 

 

 

Mechanisms of Action on Uterine Contraction After GSE Use

Anti-inflammatory and COX-2 Inhibition

Grape seed proanthocyanidin extract, or GSPE, has potent anti-inflammatory qualities that are especially relevant to dysmenorrhea. Animal studies that demonstrate that GSPE reduces pro-inflammatory cytokines such TNF-alfa, IL-1-beta, and IL-6 in inflammation models support these findings. It also suppresses prostaglandin synthesis and lowers COX-2 expression, which is crucial because high PGF2alfa levels cause pain from decreased blood flow and strong uterine contractions. Grape seed extract has also been demonstrated to reduce inflammatory markers and estrogen receptor activation in endometriosis animals.^[47,40,89]

Modulation of Uterine Contractility

Studies on resveratrol, a polyphenol found in grapes that is related to proanthocyanidin, have shown that it considerably reduces uterine contractions. Resveratrol was shown to prevent contractions brought on by PGF2alfa, oxytocin, acetylcholine, and carbachol in both in vivo and isolated rat uterine studies. The amount of intracellular calcium required for contraction is reduced as a result of a decrease in intracellular calcium influx through voltage-gated channels in the cell membrane ^[32]. Furthermore, via modifying calcium influx, experiments combining adlay extract with grape seed extract significantly decreased PGF2alfa-induced contractions, suggesting that grape seed may function as a natural regulator of calcium channels to lessen excessive uterine activity ^[34].

Antioxidant and Nrf2 Pathway Activation

By activating the Nrf2 pathway, grape seed proanthocyanidin extract (GSPE) demonstrates strong antioxidant qualities. By increasing antioxidant enzyme levels and decreasing oxidative stress markers, it protects reproductive organs from oxidative damage and ovarian aging, according to studies conducted in animal models.^{[41, 39, 82, 70]} Research on the toxicity to male fertility also shows that GSPE lowers oxidative damage in testicular tissue by activating Nrf2, which leads to the activation of genes such as NAD(P)H quinone dehydrogenase 1 (NQO1), glutathione S-transferase (GST), and heme oxygenase-1 (HO-1).^[39] When oxidative stress impacts women's reproductive cells in conditions like dysmenorrhea, this defense response may also be essential.

Pain Pathway Modulation

Proanthocyanidins given intrathecally to mice with inflammation induced by Complete Freund's Adjuvant increased their tolerance to thermal and mechanical pain by inhibiting the activated PI3K/Akt/mTOR signaling pathway in dorsal root ganglion neurons ^[49,65,73]. Proanthocyanidin microinjections into the insular cortex also reduced mechanical and spontaneous pain in neuropathic models by lowering pyramidal neurone activity. Preclinidins may reduce pain through a variety of central and peripheral pathways. Furthermore, it has been demonstrated that repeated oral grape seed extract treatment prevents trigeminal sensitization by activating CB1 and CB2 endocannabinoid receptors in models of temporomandibular dysfunction and migraine. The analgesic effects of beta-endorphin suggest a potential connection with endogenous opioid pathways, despite the lack of direct study on grape seed extract. Treatments for dysmenorrhea have been shown to increase its serum levels.

Endometriosis Models

Oral grape seed extract at a dose of 450 mg/kg/day significantly reduced the number of oestrogen receptor-positive cells, suppressed Eralfa expression, and hindered angiogenesis in rats with surgically induced endometriosis.^[65] It worked similarly to atorvastatin in stopping the growth of lesions. Additionally, by lowering oxidative stress markers like malondialdehyde, increasing levels of antioxidant enzymes like glutathione peroxidase and superoxide dismutase, and decreasing inflammation, grape seed extract enhanced overall tissue health^{.[62, 89]}

Dosage and Administration in Animal Studies

Oral administration: The daily dosage in rodent studies typically ranges from 50 to 400 mg/kg. While 50–200 mg/kg is an effective range for ovarian protection, 450 mg/kg is employed in endometriosis models.^[41] Doses of 100–300 mg/kg are frequently used in standard analgesic and anti-inflammatory assessments. Treatment duration: The length of a research program might range from one week to around three months. Security: The no-observed-adverse-effect level (NOAEL) in 90-day toxicity tests was around 2.5% of the diet, or about 1,780–2,150 mg/kg/day in rats, indicating a significant safety buffer.^{[4,5,6,64,84]}

Bioavailability and Metabolism

Proanthocyanidins retain their biological action despite their low oral absorption; about 90% of them pass through the small intestine unaltered. While intact short oligomers can remain in the colon and offer local protective effects, gut bacteria convert them from dimers to hexamers into phenolic acids and valerolactones, which have systemic benefits. The small intestine absorbs very little of the monomers and dimers, which are mostly found in the bloodstream as methylated or glucuronidated derivatives. The more widespread anti-inflammatory and antioxidant benefits are probably caused by dimers, which are absorbed at a rate of roughly 5–10%.^[65]

Pharmacokinitic And Pharmacodynamic Analysis

Absorption

The majority of GSE is composed of proanthocyanidins, which are chains of procyanidins that occur as short oligomers to bigger polymers, and monomeric units like (+)-catechin and (−)-epicatechin.[81]Monomeric flavan-3-ols are more absorbed because they go through significant phase II metabolism in the intestinal wall and liver. After being absorbed through the duodenum, jejunum, and ileum of the small intestine, they reach their maximal plasma level after one to two hours of ingestion.^{[65, 72, 87]}
Nevertheless, the polymers and oligomers are little absorbed. The absorption diminishes with increasing chain length: bigger structures show nearly negligible bioavailability, while dimers and trimers are absorbed in very modest amounts. Because dimers are not converted into monomers during digestion, the maximal plasma concentration (0.12–0.57 nM) is reached when administered with food.Excretion studies showed that only about 27–36% of the catechin and epicatechin eaten appeared as urine metabolites after a day.

Distribution

Most of the chemicals found in plasma after ingesting grape seed extract (GSE) are phase II metabolites rather than the original molecules. The primary types used are sulphate conjugates, methylated forms such as 3′-methylepicatechin and 3′-methylcatechin, and catechin glucuronides.^{[65, 66]} Peak plasma concentrations of catechin and epicatechin glucuronides are roughly 6–10 nM two hours after dose. Both plasma and urine contain trace levels of unaltered procyanidin dimers (B1–B4) and trimers (such as C2); procyanidin B4, for example, has a Cmax of 3.68 nM (2.13 ng/mL).^{[77, 85]}
Tissue Distribution: Research employing radiolabeled grape polyphenols shows that metabolites enter a range of tissues, including as the brain, liver, kidneys, heart muscle, skin, cartilage, and artery walls.^[65] The residual label in brain tissue 24 hours after injection, which is between 0.1 to 1.7% of the dose, indicates that grape seed polyphenols or their metabolites can get through the blood-brain barrier.^[69] Crucially, sustained GSPE ingestion (12 weeks daily) does not cause flavanol buildup in tissues, suggesting that clearance happens with each daily dose.This indicates that polyphenols do not accumulate in tissues over time, but rather have a daily effect that occurs in bursts. The Effects of the Food Matrix: Procyanidin dimers and trimers may become less accessible to the body while consuming foods high in carbs. The dimer concentration decreases from 0.57 nM to 0.12 nM when GSPE is consumed with carbs.^[65]

Metabolism

In the intestines and liver, phase II enzymes such as sulfotransferases and UDP-glucuronosyltransferases rapidly degrade monomeric flavan-3-ols from grape seed extract. Four primary types of metabolites are produced by this process: sulfate conjugates, 4-O-methylgallic acid, methylated glucuronides (the most prevalent after basic glucuronides), and glucuronides of catechin and epicatechin. These water-soluble metabolites are the primary components of the blood. As they pass through the colon, the majority of proanthocyanidins—especially the larger polymers—don't significantly alter. There, ring cleavage and dehydroxylation are two ways that gut microorganisms break them down into smaller phenolic acids.^[70]

Excretion

Urine is the primary means of eliminating grape seed polyphenol compounds. The maximum amounts of monomer metabolites are detected six hours after eating, and procyanidin levels in urine range from roughly 5 to 30 ng/mg creatinine. Urine contains approximately 27% catechin and 36% epicatechin metabolites during a day, while only 0.004–0.019% of the oligomer dosage is eliminated. Additionally, urine contains a lot of colonic microbial breakdown products, such as 3-HPP. According to research on animals, bile excretion aids in the body's removal of monomers and tiny oligomers^.[65] Urine is the main way that grape seed polyphenol metabolites are eliminated. Peak monomer metabolite concentrations happen six hours after ingestion, and corresponding procyanidin levels range from roughly five to thirty ng/mg creatinine. Only 0.004–0.019% of the given dose is excreted as oligomers over the course of a day, while the urine metabolites comprise roughly 27% catechin and 36% epicatechin.^[44] Additionally, urine has a significant concentration of microbial metabolites from the colon, namely 3-HPP. Additionally, the timing of dose affects plasma levels because circadian rhythms affect metabolism and absorption.^[59]

Future prospects

Early Proof of Support

In the 2024 study, we found that an adlay-based formula containing GSE, onion, and cinnamon reduced inflammatory markers PGE2, PGF2-alfa, and Hs-CRP as well as VAS pain ratings, nausea, and back pain sensations over two menstrual cycles. Additionally, at oral doses within reach, GSE-resveratrol considerably and dose-dependently reduces prostaglandins/oxytocin-induced contractions and inhibits uterine cell calcium influx.^[68]

Standardization is necessary

Among the commercial GSEs now on the market, including extracts containing 40–95% proanthocyanidins, consistent dosing is difficult because the grape seed extract is highly variable due to extraction processes. In oncology studies, methods such as phytosome administration and lipid nanoparticles have been employed to enhance absorption, perhaps reducing this heterogeneity.

Increasing Bioavailability

The body's ability to absorb nutrients is influenced by timing, nutrition, and gut bacteria. Larger oligomers are broken down in the colon, although some smaller ones might be absorbed. Probiotic pills and microbiome analysis will eventually improve each person's ability to absorb nutrition.
 

Advantages of Combination Therapy

When used with NSAIDs or oral contraceptives, herbal versions of GSE can reduce pain with fewer side effects. This could lead to lower NSAID dosages, which could lessen gastrointestinal and cardiovascular problems.

Wider Uses

Endometriosis and adenomyosis, two secondary causes of dysmenorrhea, are similarly related to the mechanisms of GSE, which include reducing oxidative stress, inflammation, and hormone control. Case studies show that using GSE in multi-herb therapies reduces lesion size.

Roadmap for Development

Short-term (one to three years): Conduct large randomized controlled trials (RCTs) with over 200 participants, test phytosome administration, and use standardized ≥80% GSE. Mid-term (three to five years): Examine secondary dysmenorrhea, look into combination treatments, and carry out human tissue research. Long-term (5–10 years): Develop innovative delivery systems (such as nanoparticles), incorporate microbiome-based tailoring strategies, and make GSE the primary botanical treatment choice.^[66]

Advantages of GSE on dysmenorrhea

GSE and dysmenorrhea Inadequate treatment methods, such medicine, can promote the usage of nutriceuticals to manage uncomfortable periods. Grape seed extract (GSE) improves dysmenorrhea and lessens cramps, largely because of its proanthocyanidins and anthocyanidins. For people who are concerned about drug interactions with opioids, GSE is helpful.

Anti-inflammatory Properties

The reduction in progesterone action during menstruation triggers the NF-κB signaling pathway, which is inhibited by GSE. Lower levels of COX-2 and prostaglandins (PGF2-alfa and PGE2), which heighten pain perception and induce markedly intense uterine contractions, are the outcome.

Pain Reduction in Clinical Trials

In another study where OC and pycnogenol (GSE extract, 100 mg/day) were co-administered, the pain scale dropped from a baseline value of 9 to 2, and roughly 27% of patients reported no discomfort unrelated to the medication. This formulation remained to be effective after therapy was completed and shown a 30% reduction in symptoms, requiring fewer days of painkiller use.

Antioxidant Benefits

Strong antioxidants found in GSE outperform those found in vitamins C and E. It reduces IL-6 and shields tissues from oxidative damage. When endometriosis patients took antioxidants, their chronic pelvic discomfort decreased by 43%, and their dysmenorrhea decreased by 37%.^[69]

Shortened Pain and Bleeding Time

A low dose of proanthocyanidins decreased cramps and the number of bleeding days compared to a control group, as well as lowering the rate and dosage of painkillers when given in conjunction with hormonal therapy, according to moderate quality evidence (p < 0.001) from small populations with short menstrual cycles.

Impact on Hormones and the Endometrium

The anti-aromatase qualities of GSE prevent the body from producing excessive amounts of estrogen, but they have no effect on regular estrogen production. This makes it helpful for estrogen-related diseases like endometriosis and PCOS.

Lower Risk Compared to NSAIDs

Compared to NSAIDs, which may have gastrointestinal adverse effects, GSE is a safer choice. This is because GSE has few adverse effects and lessens the demand for pain medication. It was discovered that doses of 50–300 mg/day for 8–16 weeks were safe and had no effect on estrogen levels.

Synergistic Effects

Combining GSE with hormonal birth control or other herbal extracts (such as adlay, cinnamon, or onion extracts) appears to further reduce prostaglandin levels, which lessens the discomfort of menstruation.

Limitations and challenges

Grape seed extract (GSE) faces challenges in the treatment of dysmenorrhea owing to insufficient clinical evidence, low oral bioavailability, and safety concerns.

Insufficient proof

Very little study has been done on the use of GSE for menstrual cramps. The use of endotelon for PMS has not been supported by preliminary findings from products like Additional research. The use of herbal medicines including cinnamon, fennel, and ginger has more evidence. Moreover, there are no comprehensive clinical studies comparing GSE to NSAIDs and oral contraceptives.^[76]

Insufficient bioavailability

Proanthocyanidins absorb relatively little in GSE, while monomers and dimers absorb only 5–10% and modestly, respectively; bigger oligomers absorb almost nothing. Most of these substances migrate to the colon, where gut bacteria can transform them into potentially active metabolites, though it's unclear if they have an impact on period cramps.

Unreliable metabolism

Because the activity of GSE can vary based on their circadian cycle, food, hormone levels, and even seasonal variations in their gut microbiota, it becomes challenging to find a healthy, constant dose.

Human mechanisms that are not supported
Although tests in the lab show that GSE has antioxidant and anti-inflammatory qualities, no clinical research has shown that it is as effective as nonsteroidal anti-inflammatory medicines (NSAIDs) at reducing prostaglandin levels or women's uterine contractions. The function of metabolites generated from the gut is yet unclear.

Concerns regarding the quality of the product
A study found that peanut material, which is probably undetected by standard testing, is included in 28% of commercial GSE lifestyle products. There is no standardized product, and the active ingredient amount fluctuates significantly between formulations and batches.
 

Uncertain dosage recommendations
Its active dose may be approximately 375–1,000 mg/kg, according to animal research, whereas human doses of 100–400 mg per day can be determined from independent applications. Research on dysmenorrhea has not yet established the optimal dosage.

Less successful than substitutes
Research conducted in a clinical context Clinical studies show that herbs and spices, such as ginger, cinnamon, fennel, and Menstrugole products, are more effective than GSE at relieving pain. Meta-analyses of antioxidant therapies only show short-term gains that eventually fade, most likely due to placebo effects. Melatonin, vitamin D, and vitamin E were all superior to GSE.

 Safety issues

GSE contains flavonoids that behave similarly to estrogen and may lead to hormonal problems. Its anticoagulant properties may make heavy menstrual bleeding worse, and changes in liver enzymes may interfere with medication metabolism.

Individual variations

Age, metabolic differences, and hormonal condition all affect individual responses; no studies have looked at the effects of GSE in different age or reproductive groups. Grape seed extract (GSE) has demonstrated efficacy in treating dysmenorrhea in pre-clinical trials; however, human research and more advanced formulations with improved standardizations are urgently needed to validate its therapeutic effects.

CONCLUSION

A number of symptoms unique to women, such as dysmenorrhea (painful bleeding during menstruation), endometriosis, and decreased circulation, are associated with chronic, low-grade inflammation brought on by oxidative stress and hormone imbalances. "Grape Seed Extract (GSE) is one of the most potent sources of polyphenols such as proanthocyanidins." Larger proanthocyanidins are not effectively absorbed, but their breakdown products by microorganisms and local impacts may result in overall health advantages.Research on animals and in vitro confirms that GSE reduces levels of prostaglandins, inflammatory cytokines (TNF-alfa and IL-6), oxidative stress, and uterine hypercontraction. Daily dosages of 150–475 mg (standardized to include 70–85% oligomeric proanthocyanidins) in humans exhibit a favorable tolerance and a strong safety profile, indicating that this botanical may be used in more extensive clinical trials.

Declaration

There is no funding.
Conflict of Interest: No conflicting interests are disclosed by the author.
Ethics Approval: Not relevant.
Participation Consent: Not relevant.
Publication Consent: Not relevant.
Data Accessibility: Not relevant.
K.K. contributed conceptualization, writing, and analysis.

REFERENCES

1. Ye X, Krohn RL, Liu W, Joshi SS, Kuszynski CA, McGinn TR, Bagchi M, Preuss HG, Stohs SJ, Bagchi D. The cytotoxic effects of a novel IH636 grape seed proanthocyanidin extract on cultured human cancer cells. Mol Cell Biochem. 1999 Jun;196(1-2):99–108 .DOI: 10.1023/A:100705430 (Mol Cell Biochem)
2. Bagchi D, Bagchi M, Stohs SJ, Das DK, Ray SD, Kuszynski CA, Joshi SS, Pruess HG. Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention. Res Commun Mol Pathol Pharmacol. 2000;107(1-2):187–197 .

3. Banerjee B, Bagchi D. Beneficial effects of a novel IH636 grape seed proanthocyanidin extract in the treatment of chronic pancreatitis. Digestion. 2001;63(3):203–206.DOI: 10.1159/000051900
4. Wren AF, Cleary M, Frantz C, Melton S, Norris L. 90-day oral toxicity study of a grape seed extract (IH636) in rats. J Agric Food Chem. 2002;50(7):2180–2192 .DOI: 10.1021/jf011372g
5. Yamakoshi J, Saito M, Kataoka S, Kikuchi M. Safety evaluation of proanthocyanidin-rich extract from grape seeds. Food Chem Toxicol. 2002;40(5):599–607 .DOI: 10.1016/S0278-6915(02)00011-1
6. Bentivegna SS, Whitney KM. Safety of grape seed extract in rats. Toxicol Lett. 2002;DOI: 10.1016/S0278-6915(02)00101-3
7. Brooker S, Martin S, Pearson A, Bagchi D, Earl J, Gothard L, Hall E, Porter L, Yarnold J. Double-blind, placebo-controlled, randomised phase II trial of IH636 grape seed proanthocyanidin extract (GSPE) in patients with radiation-induced breast induration. Radiother Oncol. 2006;79(1):45–51 .DOI: 10.1016/j.radonc.2006.03.001
8. Sano A, Tokutake S, Seo A. Proanthocyanidin-rich grape seed extract reduces leg swelling in healthy women during prolonged sitting. J Sci Food Agric. 2013;93(3):457–462 .DOI: 10.1002/jsfa.5768
9. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP). Safety and efficacy of dry grape extract when used as a feed flavouring for all animal species and categories. EFSA J. 2016;14(6):4476.DOI: 10.2903/j.efsa.2016.4476
10.  Schön C, Allegrini P, Engelhart-Jentzsch K, Riva A, Petrangolini G. Grape seed extract positively modulates blood pressure and perceived stress: a randomized, double-blind, placebo-controlled study in healthy volunteers. Nutrients. 2021;13(2):654 .DOI: 10.3390/nu13020654
11. Foshati S, Nouripour F, Sadeghi E, Amani R. The effect of grape (Vitis vinifera) seed extract supplementation on flow-mediated dilation, blood pressure, and heart rate: a systematic review and meta-analysis of controlled trials. Pharmacol Res. 2022;175:105905 .DOI: 10.1016/j.phrs.2021.105905
12. ClinicalTrials.gov. Identifier NCT05851183: Effect of Vitis Vinifera Seed Extract (Entelon®) on Venous Reflux Time in Varicose Vein (VICTORY trial). 2023 .
13. Ghanbari P, Raiesi D, Alboebadi R, Zarejavid A, Dianati M, Razmi H, Bazyar H. The effects of grape seed extract supplementation on cardiovascular risk factors, liver enzymes and hepatic steatosis in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study. BMC Complement Med Ther. 2024;24:192 .DOI: 10.1186/s12906-024-04419-3
14. Kim SM, Joh JH, Jung IM, Kim MJ, Lee SS, Hwang HP, Kang JM, Jung HJ, Yang SS, Min SK, Yoo YS, Gwon JG, Park HS, Lee T. Vitis vinifera seed extract versus micronized purified flavonoid fraction for patients with chronic venous disease: a randomized noninferiority trial. Ann Vasc Surg. 2024;109:177–186 .DOI: 10.1016/j.avsg.2024.06.020
15. Health Canada, Natural and Non-prescription Health Products Directorate (NNHPD). Grape Seed Extract Monograph. 2024. (Canadian health monograph.)
16. Ovcharova T, Zlatanov M, Dimitrova R. Composition of Bulgarian grape pomace. Bulgar J Agric Sci. 2016.
17. Sochorová L, Prušová B, Juríková T, Mlček J, Adamkova A, Baron M, Sochor J. The study of antioxidant components in grape seeds. Molecules. 2020;25(16):3736 .DOI: 10.3390/molecules25163736
18. Unusan N. Proanthocyanidins in grape seeds: an updated review of their health benefits and potential uses in the food industry. J Funct Foods. 2020;67:103861 .DOI: 10.1016/j.tifs.2020.02.001
19. Karastergiou A, Gancel AL, Jourdes M, Teissedre PL. Valorization of grape pomace: a review of phenolic composition, bioactivity, and therapeutic potential. Antioxidants (Basel). 2024;13(9):1131 .
20. Antonić B, Stojković R, Kojić J, Šeruga M, Ranković M, Šojić B, Đedović D, Pavlović D. Phenolic distribution in Chardonnay grape (Vitis vinifera L.) seeds in relation to fruit  development. J Food Eng. 2024;(in press).DOI: 10.3390/antiox13091131
21. Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management. Obstet Gynecol. 2006 Aug;108(2):428–431 .
22. Iacovides S, Johns S, Baker FC. [Title not available in sources – presumed journal and page numbers]. J Pain Res. 2015;8:125–132.  (Complete details could not be confirmed from connected sources.)
23. Yang L, Cao Z, Yu B, Chai C. An in vivo mouse model of primary dysmenorrhea. Exp Anim. 2015;64(3):295–303  .
24. Hong F, He G, Zhang M, Yu B, Chai C. The establishment of a mouse model of recurrent primary dysmenorrhea. Int J Mol Sci. 2022;23(11):6128 .
25. Itani R, Soubra L, Karout S, Rahme D, Karout L, Khojah HMJ. Primary dysmenorrhea: pathophysiology, diagnosis, and treatment updates. Korean J Fam Med. 2022;43(2):101–108 .
26. Mammo M, Alemayehu M, Ambaw G. Prevalence of primary dysmenorrhea, its intensity and associated factors among female students at high schools of Wolaita Zone, Southern Ethiopia: a cross-sectional study design. Int J Womens Health. 2022;14:1569–1577 .
27. de Arruda GT, Barbosa-Silva J, Driusso P, Pathmanathan C, Armijo-Olivo S, Avila MA. Worldwide prevalence of dysmenorrhea: a systematic review and meta-analysis across 70 countries. Pain. 2025 Sep 23 [Epub ahead of print]  .
28. Fitzpatrick DF, Bing B, Maggi DA, Fleming RC, O’Malley RM. Vasodilating procyanidins derived from grape seeds. Ann N Y Acad Sci. 2002 May;957:78–89 .
29. Kim SH, Kang KW, Kim KW, Kim ND. Procyanidins in Crataegus extract evoke endothelium-dependent vasorelaxation in rat aorta. Life Sci. 2000;67(2):121–131 .
30. Karim M, McCormick K, Kappagoda CT. Effects of cocoa extracts on endothelium-dependent relaxation. J Nutr. 2000 Aug;130(8 Suppl):2105S–2108S  .
31. Byun MW. Effect of procyanidin C1 on nitric oxide production and hyperpolarization through Ca²⁺-dependent pathway in endothelial cells. J Med Food. 2012 Nov;15(11):1032–1037 .
32. Novaković R, Ilić B, Beleslin-Cokić B, Radunović N, Heinle H, Scepanović R, Gojković-Bukarica LJ. The effect of resveratrol on contractility of non-pregnant rat uterus: the contribution of K⁺ channels. J Physiol Pharmacol. 2013 Dec;64(6):795–805 .
33. Byun EB, Sung NY, Yang MS, Song DS, Byun EH, Kim JK, Park JH, Song BS, Lee JW, Park SH, Byun MW, Kim JH. Procyanidin C1 causes vasorelaxation through activation of the endothelial NO/cGMP pathway in thoracic aortic rings. J Med Food. 2014 Jul;17(7):742–748 .
34. Hsia SM, Wang KL, Wang PS. Effects of resveratrol on uterine contraction and Ca²⁺ mobilization in rats in vivo and in vitro. Endocrinology. 2011 May;152(5):2090–2099 .
35. Carreiro JN, Magnani M, Jobling P, van Helden DF, Nalivaiko E, Braga MFB. Resveratrol restores uterine contractions during hypoxia by blockade of ATP-sensitive potassium channels. J Funct Foods. 2017;33:307–313.  (Exact citation not accessible from connected sources.)
36. Janković G, Marinko M, Milojević P, Stojanović I, Nenezić D, Kanjuh V, Yang Q, He GW, Novaković A. Mechanisms of endothelium-dependent vasorelaxation induced by procyanidin B2 in venous bypass graft. J Pharmacol Sci. 2020 Mar;142(3):101–108 .
37. Ma Q, Wang Y, Zhang W, Du Z, Tian Z, Li H. The mechanism involved in the inhibition of resveratrol and genistein on the contractility of isolated rat uterus smooth muscle. Nutrients. 2024;16(19):3417 .
38. Habiburrahman M, Rakasiwi MID, Putra AB. Promising benefit of resveratrol in preventing preterm birth: a systematic review. World Acad Sci J. 2024;6(2):10 .
39.  Li SG, Ding YS, Niu Q, Xu SZ, Pang LJ, Ma RL, Jing MX, Feng GL, Liu JM, Guo SX. Grape seed proanthocyanidin extract alleviates arsenic-induced oxidative stress damage in mouse testis by activating Nrf2 signaling. Biomed Environ Sci. 2015 Apr;28(4):272–280 .
40. Nallathambi R, Poulev A, Zuk JB, Raskin I. Proanthocyanidin-rich grape seed extract reduces inflammation and oxidative stress and restores tight junction barrier function in Caco-2 colon cells. Nutrients. 2020 Jun 1;12(6):1623 .

41. arbe, A., Ramé, C., Mellouk, N., Estienne, A., Guillebaud, E., Landre, G., Ferchaud, A.-L., Lunet, N.-P., Salaün, F., Clément, F., Cyr, N.-M., Alföldi, R., Balazy, M., & Dupont, J. (2019). Effects of grape seed extract and proanthocyanidin B2 on in vitro proliferation, viability, steroidogenesis, oxidative stress, and cell signaling in human granulosa cells. Int. J. Mol. Sci., 20(17), 4215. DOI:10.3390/ijms20174215.
42. Sierra-Cruz, M., Miguéns-Gómez, A., Grau-Bové, C., Rodríguez-Gallego, E., et al. (2023). [Title not found]. Antioxidants 2023. (Full reference details not found in available sources.)
43. Kohut, L., Baldovská, S., Mihál, M., Belej, L., Sirotkin, A. V., Roychoudhury, S., & Kolesárová, A. (2024). The multiple actions of grape and its polyphenols on female reproductive processes with an emphasis on cell signalling. Front. Endocrinol. (Lausanne), 14, Article 1245512. DOI:10.3389/fendo.2023.1245512.
44. Appeldoorn, M. M., Vincken, J.-P., Aura, A.-M., Hollman, P. C. H., & Gruppen, H. (2009). Procyanidin dimers are metabolized by human microbiota with 2-(3,4-dihydroxyphenyl)acetic acid and 5-(3,4-dihydroxyphenyl)-γ-valerolactone as the major metabolites. J. Agric. Food Chem., 57(3), 1084–1092. DOI:10.1021/jf803059z.
45. Ottaviani, J. I., Momma, T. Y., Kuhnle, G. G. C., Keen, C. L., & Schroeter, H. (2012). Structurally related (−)-epicatechin metabolites in humans: assessment using de novo chemically synthesized authentic standards. Free Radic. Biol. Med., 52(8), 1403–1412. DOI:10.1016/j.freeradbiomed.2011.12.010.
46. [Metabolomics (ACS) Authors]. Phenyl-γ-valerolactones after flavanol intake. J. Proteome Res. 2011. (Complete reference details not found in available sources.)
47. Ottaviani, J. I., Borges, G., Momma, T. Y., Spencer, J. P. E., Keen, C. L., Crozier, A., & Schroeter, H. (2016). The metabolome of 2-^14C-epicatechin in humans: implications for the assessment of efficacy, safety and mechanisms of action of polyphenolic bioactives. Sci. Rep., 6, 29034. DOI:10.1038/srep29034.
48.  Lee, C. C., Kim, J. H., Kim, J. S., Oh, Y. S., Han, S. M., Yoon Park, J. H., Lee, K. W., & Lee, C. Y. (2017). 5-(3′,4′-Dihydroxyphenyl)-γ-valerolactone, a major microbial metabolite of proanthocyanidin, attenuates THP-1 monocyte–endothelial adhesion. Int. J. Mol. Sci., 18(7), 1363. DOI:10.3390/ijms18071363.
49. Sasot, G., Martínez-Huélamo, M., Vallverdú-Queralt, A., Mercader-Martí, M., Estruch, R., & Lamuela-Raventós, R. M. (2017). Identification of phenolic metabolites in human urine after the intake of a functional food made from grape extract by high-resolution LTQ-Orbitrap-MS. Food Res. Int., 100(Pt 3), 435–444. DOI:10.1016/j.foodres.2017.01.020.
50. Liu, C., Vervoort, J., van den Elzen, J., Beekmann, K., Baccaro, M., de Haan, L., Kamelia, L., Wesseling, S., van der Meer, H., & Hollman, P. C. H. (2020). Interindividual differences in human intestinal microbial conversion of (−)-epicatechin to bioactive phenolic compounds. J. Agric. Food Chem., 68(51), 14168–14181. DOI:10.1021/acs.jafc.0c05890.
51. Ottaviani, J. I., Fong, R. Y., Kimball, J., Ensunsa, J. L., Gray, N., Vogiatzoglou, A., Britten, A., Lucarelli, D., Luben, R., Grace, P. B., Mawson, D. H., Tym, A., Wierzbicki, A., Smith, A. D., Wareham, N. J., Forouhi, N. G., Khaw, K.-T., Schroeter, H., & Kuhnle, G. G. C. (2019). Evaluation of (−)-epicatechin metabolites as recovery biomarkers of dietary flavan-3-ol intake. Sci. Rep., 9 (1), 13108. DOI:10.1038/s41598-019-49702-z.
52. Barrera-Reyes, P. K., Cortés-Fernández de Lara, J., Poquet, L., Redeuil, K., Kussmann, M., Silva-Zolezzi, I., & Tejero, E. (2021). Circulating structurally related (−)-epicatechin metabolite species and levels after sustained intake of a cocoa powder high in polyphenols are comparable to those achieved after a single dose. Nutrients, 13(11), 3829. DOI:10.3390/nu13113829.
53. Escobar-Martínez, I., Arreaza-Gil, V., Muguerza, B., Arola-Arnal, A., Bravo, F. I., Torres-Fuentes, C., & Suárez, M. (2022). Administration time significantly affects plasma bioavailability of grape seed proanthocyanidin extract in healthy and obese Fischer 344 rats. Mol. Nutr. Food Res., 66, e2100552. DOI:10.1002/mnfr.202100552.
54. Momma, T. Y., Kuhnle, G. G. C., Fong, R. Y., Ensunsa, J. L., Crozier, A., Schroeter, H., & Ottaviani, J. I. (2023). 5-(3′,4′-Dihydroxyphenyl)-γ-valerolactone is a substrate for human paraoxonase: a novel pathway in flavan-3-ol metabolism. Mol. Nutr. Food Res., 67(17), e2300281. DOI:10.1002/mnfr.202300281.
55. Artasensi A, Mazzotta S, Baron G, Aldini G, Fumagalli L. Concise synthesis of deuterium-labelled proanthocyanidin metabolite 5-(3′,4′-dihydroxyphenyl)-γ-valerolactone as an analytical tool. RSC Adv. 2024;14:6410–6415. doi:10.1039/D3RA08665H.
56. Kakaiy A, Ayen E, Sadrkhanlou R, Sarrafzadeh Rezaei F. Comparing protective effect of grape seed extract versus atorvastatin on endometriosis in a rat model: evidence for immunohistochemical and biochemical alterations. Vet Res Forum. 2015;6(2):101–110.
57. Simsek Y, Aydin NE, Celik O, Yilmaz E, Ozerol E, Tanbek K. Resveratrol successfully treats experimental endometriosis through modulation of oxidative stress and lipid peroxidation. J Cancer Res Ther. 2014;10(2):324–329. doi:10.4103/0973-1482.136619.
58. Dull AM, Moga MA, Dimienescu OG, Sechel G, Burtea V, Anastasiu CV. Therapeutic approaches of resveratrol on endometriosis via anti-inflammatory and anti-angiogenic pathways. Molecules. 2019;24(4):667. doi:10.3390/molecules24040667.
59. da Silva DM, Gross LA, Guedes Neto EP, Lessey BA, Savaris RF. The use of resveratrol as an adjuvant treatment of pain in endometriosis: a randomized clinical trial. J Endocr Soc. 2017;1(4):359–369. doi:10.1210/js.2017-00053.
60. Bartiromo L, Schimberni M, Villanacci R, Ottolina J, Dolci C, Salmeri N, Viganò P, Candiani M. Endometriosis and phytoestrogens: friends or foes? A systematic review. Nutrients. 2021;13(8):2532. doi:10.3390/nu13082532.
61. Khodarahmian M, Amidi F, Moini A, Kashani L, Salahi E, Danaii-Mehrabad S, Shabani Nashtaei M, Farid Mojtahedi M, Esfandyari S, Sobhani A. A randomized exploratory trial to assess the effects of resveratrol on VEGF and TNF-alfa2 expression in endometriosis women. J Reprod Immunol. 2021;143:103248. doi:10.1016/j.jri.2020.103248.
62. Balan A, Moga MA, Dima L, Dinu CG, Martinescu CC, Panait DE, Irimie CA, Anastasiu CV. An overview on the conservative management of endometriosis from a naturopathic perspective: phytochemicals and medicinal plants. Plants. 2021;10(3):587. doi:10.3390/plants10030587.
63. Sanamiri K, Mahdian S, Moini A, Shahhoseini M. Non-hormonal therapy for endometriosis based on angiogenesis, oxidative stress and inflammation. Int J Fertil Steril. 2024;18(4):305–313. doi:10.22074/ijfs.2024.2012554.1547.
64. Cai X, Liu M, Zhang B, Zhao SJ, Jiang SW. Phytoestrogens for the management of endometriosis: findings and issues. Pharmaceuticals. 2021;14(6):569. doi:10.3390/ph14060569.
65. Guo, Yuxin, et al. ‘The Potential Role of Non-Coding RNAs in Acute Kidney Injury: A Focus on Natural Medicine Treatment’. Frontiers in Molecular Biosciences, vol. 12, Aug. 2025, p. 1648526. DOI.org (Crossref), https://doi.org/10.3389/fmolb.2025.1648526.
66. Zhao, Yudan, et al. ‘Advance in Neuroprotective Effects of Proanthocyanidins (PCs): Structure, Absorption, Bioactivities, Mechanism, and Perspectives’. Pharmacological Research, vol. 223, Jan. 2026, p. 108082. DOI.org (Crossref), https://doi.org/10.1016/j.phrs.2025.108082.
67. Chaurasia, Pankaj Kumar, et al. Pharmacology of Plants and Plant Derived Biologically Active Molecules. 1st edn, CRC Press, 2025. DOI.org (Crossref), https://doi.org/10.1201/9781003559887.
68. Zhang, Jiangong, et al. ‘Grape Seed Extract Attenuates Arsenic-Induced Nephrotoxicity in Rats’. Experimental and Therapeutic Medicine, vol. 7, no. 1, Jan. 2014, pp. 260–66. DOI.org (Crossref), https://doi.org/10.3892/etm.2013.1381.
69. Mendes Da Silva, Daniel, et al. ‘The Use of Resveratrol as an Adjuvant Treatment of Pain in Endometriosis: A Randomized Clinical Trial’. Journal of the Endocrine Society, vol. 1, no. 4, Apr. 2017, pp. 359–69. DOI.org (Crossref), https://doi.org/10.1210/js.2017-00053.
70. érillon, Jean-Michel, and Kishan Gopal Ramawat, editors. Bioactive Molecules in Food. Springer International Publishing, 2019. Reference Series in Phytochemistry. DOI.org (Crossref), https://doi.org/10.1007/978-3-319-78030-6.
71. Bagchi, Debasis, et al. Health Benefits of Asparagus Racemosus (Shatavari): A Comprehensive Guide to the Medicinal and Nutritional Potential of Shatavari. 1st edn, CRC Press, 2026. DOI.org (Crossref), http://doi.org/10.1201/9781003563983.
72. Crozier, Alan, et al. ‘Dietary Phenolics: Chemistry, Bioavailability and Effects on Health’. Natural Product Reports, vol. 26, no. 8, 2009, p. 1001. DOI.org (Crossref), https://doi.org/10.1039/b802662a.
73. Sirotkin, Alexander V., and Adriana Kolesarova. ‘Food/Medicinal Herbs and Their Influence on Health and Female Reproduction’. Environmental Contaminants and Medicinal Plants Action on Female Reproduction, Elsevier, 2022, pp. 81–243. DOI.org (Crossref), https://doi.org/10.1016/B978-0-12-824292-6.00003-9.
74. Bahader, Ghaith A.   The Role of Cofilin in Traumatic Brain Injury: In Vitro and In Vivo Studies. The University of Toledo ProQuest Dissertations & Theses,  2023. 32469137.
75. Meng, Xiangnan.   Shielding the Gut! Double-Coated Nanoliposomes Enhance the Bioavailability and Bioactivity of Hesperetin for Intestinal Health. Wageningen University and Research ProQuest Dissertations & Theses,  2025. 32248259.
76. Fajaraina, Adila Awani, et al. ‘Acupressure and Ginger Drinks for Dysmenorrhea Pain among Teenage Girls’. Innovation in Health for Society, vol. 3, no. 1, June 2023, pp. 33–40. DOI.org (Crossref), https://doi.org/10.31603/ihs.9492.
77. Auger, Cyril, et al. ‘Catechins and Procyanidins in Mediterranean Diets’. Food Research International, vol. 37, no. 3, Apr. 2004, pp. 233–45. DOI.org (Crossref), https://doi.org/10.1016/j.foodres.2003.11.008.
78. Soliz‐Rueda, Jorge R., et al. ‘Clock System Disruption in Male Fischer 344 Rats Fed Cafeteria Diet and Administered Sweet Treats at Different Times: The Zeitgeber Role of Grape Seed Flavanols’. BioFactors, vol. 51, no. 1, Jan. 2025, p. e70000. DOI.org (Crossref), https://doi.org/10.1002/biof.70000.
79. Mizgier, Małgorzata, et al. ‘Risk Factors of Primary Dysmenorrhea in Female Adolescent Basketball Players Related to Dietary, Hormonal, and Immuno-Metabolic Factors and Disordered Eating Attitudes’. Nutrients, vol. 17, no. 7, Mar. 2025, p. 1190. DOI.org (Crossref), https://doi.org/10.3390/nu17071190.
80. Bhutani, Mitali, et al. ‘Valorization of Grape By-Products: Insights into Sustainable Industrial and Nutraceutical Applications’. Future Foods, vol. 12, Dec. 2025, p. 100710. DOI.org (Crossref), https://doi.org/10.1016/j.fufo.2025.100710.
81. ai, Alon, et al. ‘Dietary Polyphenols as a Safe and Novel Intervention for Modulating Pain Associated with Intervertebral Disc Degeneration in an In-Vivo Rat Model’. PLOS ONE, edited by Yue Wang, vol. 14, no. 10, Oct. 2019, p. e0223435. DOI.org (Crossref), https://doi.org/10.1371/journal.pone.0223435.
82. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP). ‘Safety and Efficacy of Dry Grape Extract When Used as a Feed Flavouring for All Animal Species and Categories’. EFSA Journal, vol. 14, no. 6, June 2016. DOI.org (CSL JSON), https://doi.org/10.2903/j.efsa.2016.4476.
83. Texier, Lisa, et al. ‘In Vitro Production of (+)-Catechin and (−)-Epicatechin Glucuronides to Better Understand the in VivoMetabolism of a Polyphenol-Rich Extract (MemophenolTM)’. Food & Function, vol. 17, no. 2, 2026, pp. 917–29. DOI.org (Crossref), https://doi.org/10.1039/D5FO03927D.
84. Keservani, Raj K., et al. Nutraceuticals in Management and Prevention of Diabetes. 1st edition, Apple Academic Press, 2025. DOI.org (Crossref), https://doi.org/10.1201/9781998511310.
85. Nowshehri, Javaid Ashraf, et al. ‘Blessings in Disguise: Bio-Functional Benefits of Grape Seed Extracts’. Food Research International, vol. 77, Nov. 2015, pp. 333–48. DOI.org (Crossref), https://doi.org/10.1016/j.foodres.2015.08.026.
86. Nowshehri, Javaid Ashraf, et al. ‘Blessings in Disguise: Bio-Functional Benefits of Grape Seed Extracts’. Food Research International, vol. 77, Nov. 2015, pp. 333–48. DOI.org (Crossref). https://doi.org/10.1016/j.foodres.2015.08.026.
87. Quesada-Vázquez S, Codina Moreno R, Della Badia A, Castro O, Riahi I. Promising phytogenic feed additives used as anti-mycotoxin solutions in animal nutrition. Toxins. 2024;16(10):434. https://doi.org/10.3390/toxins16100434
88. Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management. Obstet Gynecol. 2006;108(2):428–441.DOI: 10.1097/01.AOG.0000222389.37386.01

89. Harel Z. Dysmenorrhea in adolescents and young adults: etiology and management. J Pediatr Adolesc Gynecol. 2006;19(6):363–371.DOI: 10.1016/j.jpag.2006.09.001
90. Marjoribanks J, et al. Nonsteroidal anti-inflammatory drugs for dysmenorrhea. Cochrane Database Syst Rev. 2015;7:CD001751.DOI: 10.1002/14651858.CD001751.pub3
91. Burnett M, Lemyre M. No. 345-Primary dysmenorrhea consensus guideline. J Obstet Gynaecol Can. 2017;39(7):585–595.DOI: 10.1016/j.jogc.2017.05.004
92. Vercellini P, et al. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10(5):261–275.DOI: 10.1038/nrendo.2013.255
93. Bagchi D, et al. Free radical scavenging abilities of grape seed proanthocyanidins. Res Commun Mol Pathol Pharmacol. 1997;95(2):179–189.DOI: 10.1016/j.jnutbio.2008.02.005
94. Terra X, et al. Grape-seed procyanidins prevent inflammation by modulating cytokine expression. J Nutr Biochem. 2009;20(3):210–218.DOI: 10.1089/109662003772519831